No connection

Search Results

LLY vs TALK

LLY
Eli Lilly and Company
NEUTRAL
Price
$958.65
Market Cap
$858.01B
Sector
Healthcare
AI Confidence
85%
TALK
Talkspace, Inc.
NEUTRAL
Price
$5.18
Market Cap
$865.5M
Sector
Healthcare
AI Confidence
85%

Valuation

P/E Ratio
LLY
41.7
TALK
129.5
Forward P/E
LLY
22.78
TALK
23.55
P/B Ratio
LLY
32.33
TALK
7.38
P/S Ratio
LLY
13.16
TALK
3.78
EV/EBITDA
LLY
27.08
TALK
128.23

Profitability

Gross Margin
LLY
83.04%
TALK
39.82%
Operating Margin
LLY
44.9%
TALK
6.08%
Profit Margin
LLY
31.67%
TALK
3.4%
ROE
LLY
101.16%
TALK
6.65%
ROA
LLY
19.41%
TALK
1.44%

Growth

Revenue Growth
LLY
42.6%
TALK
29.3%
Earnings Growth
LLY
51.4%
TALK
181.1%

Financial Health

Debt/Equity
LLY
1.65
TALK
--
Current Ratio
LLY
1.58
TALK
6.38
Quick Ratio
LLY
0.78
TALK
6.25

Dividends

Dividend Yield
LLY
0.68%
TALK
--
Payout Ratio
LLY
26.14%
TALK
0.0%

AI Verdict

LLY NEUTRAL

LLY shows neutral fundamentals based on deterministic rules. Financial strength is weak (F-Score 3/9). Mixed signals with both opportunities and risks present.

Strengths
Strong profitability (31.7% margin)
Strong revenue growth of 42.6%
Strong ROE of 101.2%
Risks
High valuation with P/E of 41.7
Premium vs Graham Number ($123.85)
Weak financial trend (Piotroski F-Score: 3/9)
TALK NEUTRAL

TALK presents a classic growth-vs-value conflict. While the Piotroski F-Score of 4/9 indicates stable financial health and the company has successfully transitioned to profitability with explosive earnings growth (181% YoY), the valuation is disconnected from deterministic baselines. The stock trades at $5.18, significantly exceeding both the Graham Number ($0.79) and Intrinsic Value ($1.18), suggesting a massive growth premium. Strong liquidity (Current Ratio 6.38) offsets the lack of an Altman Z-Score, but bearish insider activity and a weak technical trend temper the bullish growth narrative.

Strengths
Strong revenue growth of 29.30% YoY
Successful transition to profitability with 181.10% earnings growth
Exceptional liquidity with a Current Ratio of 6.38
Risks
Extreme valuation premium (P/E of 129.50)
Significant divergence from Graham Number ($0.79) and Intrinsic Value ($1.18)
Bearish insider sentiment with CTO selling shares

Compare Another Pair

LLY vs TALK: Head-to-Head Comparison

This page compares Eli Lilly and Company (LLY) and Talkspace, Inc. (TALK) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.

Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.

Home
Terminal
AI
Markets
Profile